Form 8-K - Current report:
SEC Accession No. 0001193125-24-247643
Filing Date
2024-10-30
Accepted
2024-10-30 16:56:52
Documents
15
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d894566d8k.htm   iXBRL 8-K 32615
2 EX-99.1 d894566dex991.htm EX-99.1 8410
6 GRAPHIC g894566g1030074957425.jpg GRAPHIC 4788
  Complete submission text file 0001193125-24-247643.txt   180464

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA calc-20241030.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20241030_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20241030_pre.xml EX-101.PRE 11717
18 EXTRACTED XBRL INSTANCE DOCUMENT d894566d8k_htm.xml XML 3806
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 241411164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)